国产中文无码av每日更新在线观看, 亚洲天堂中文字幕一区二区三区免费, 国产口爆吞精在线观视频-黄色国产, 92福利-国内精品久久久久久99,亚洲成AV人A片不卡无码,浪潮AV无码专区,老熟女败火白浆,中文字幕日产av,色情日本免费看大片

400-885-9898
更新于 9月3日
智聯(lián)APPAPP
舉報(bào)

PMO (Chief of Staff )(J10072)

7-10萬
  • 北京昌平區(qū)
  • 10年以上
  • 碩士
  • 全職
  • 招1人

職位描述

生物醫(yī)藥管線管理生物醫(yī)藥醫(yī)藥制造
Key Responsibilities:
1.Be responsible for elaboration of clinical development program strategy and planning, drive and guide the implementation of clinical development strategy, manage and control all the phases of clinical trials with all dimensions by establishing integrated, cross-functional, short-term and long-term program plans.
2.Serve as key contact for Clinical Development Program and related information, establish and maintain appropriate communications channels within and outside the Clinical Development Program Core Team, ensure sufficient and timely flow of information and communication, promote the identification and solution of problems., reporting directly to the CEO.
3.Engage in in-depth conversations with the CEO and the N-1 Top Management, documenting and organizing strategies for consensus and implementation.
4.Conduct or contribute to periodic key program review meetings (including, but not limited to Program Strategy meetings, Program Risk Management meetings, Lessons Learned or Program Budget reviews) in order to strive for earlier identification of critical success factors and to facilitate portfolio analysis, risk-management and decision-making; prepare meeting agendas and minutes and communicate action logs to improve the efficiency of core team.
5.Establish the implementation and tracking plans for project timeline and budget; accountable for ensuring the implementation of program/projects budget and progress; be responsible of optimized budget scenarios, maintain interaction partnership with key functions; propose the optimal clinical operations solutions and promote and maximize team work value through the integration and optimization of clinical development resource allocation.
Requirements:
1.Master in relevant scientific and/or medical, pharmacy, biology from a top university is preferred.
2.Rich experience in operation mode, workflow, ICH-GCP and other relevant regulations;
3.Rich experience in global clinical operation mode;
4.5+ years of relevant industry experience and 3+ year experience of global project management preferred;
5.Mature in conduct and demeanor, capable of handling external communications in significant situations.
6.Proficiency in English communication is required.

工作地點(diǎn)

昌平區(qū)北京諾誠健華醫(yī)藥科技有限公司

職位發(fā)布者

田野/人事經(jīng)理

三日內(nèi)活躍
立即溝通
公司Logo諾誠健華
諾誠健華（上交所代碼：688428；香港聯(lián)交所代碼：09969）于2015年由世界著名結(jié)構(gòu)生物學(xué)家施一公院士和生物醫(yī)藥行業(yè)卓越的科學(xué)家兼企業(yè)家崔霽松博士聯(lián)合創(chuàng)立。作為一家植根于中國且具有全球視野的新藥創(chuàng)制公司，諾誠健華以“科學(xué)驅(qū)動(dòng)創(chuàng)新患者所需為本”為價(jià)值理念，專注于惡性腫瘤和自身免疫性疾病的創(chuàng)新藥研究和開發(fā)。經(jīng)過近十年的堅(jiān)實(shí)發(fā)展，公司在各方面取得重大進(jìn)展。2020年3月23日，諾誠健華成功在港交所上市，成為2020年港交所生物醫(yī)藥第*一股。2022年9月21日，諾誠健華在上海證券交易所科創(chuàng)板上市，開啟了H+A的新征程。目前，諾誠健華已經(jīng)打造了具有市場前景的強(qiáng)大產(chǎn)品管線，覆蓋血液瘤、實(shí)體瘤和自身免疫性疾病。諾誠健華自主研發(fā)的國家“重大新藥創(chuàng)制”專項(xiàng)成果——BTK抑制劑奧布替尼（商品名：宜諾凱?）目前已在中國和新加坡獲批上市并納入中國國家醫(yī)保，是中國首*個(gè)且唯*一獲批針對(duì)邊緣區(qū)淋巴瘤的BTK抑制劑；坦昔妥單抗（商品名：明諾凱?）創(chuàng)新療法已成為中國首*個(gè)獲批治療復(fù)發(fā)/難治性彌漫性大B細(xì)胞淋巴瘤（R/R DLBCL）的CD19單抗；mesutoclax（ICP-248）是中國第*一個(gè)獲得突破性療法認(rèn)定（Breakthrough Therapy Designation）的BCL2抑制劑，10多款創(chuàng)新藥在臨床階段。諾誠健華已經(jīng)構(gòu)建了從源頭創(chuàng)新、臨床開發(fā)、生產(chǎn)到商業(yè)化的全產(chǎn)業(yè)鏈平臺(tái)。在具有豐富研發(fā)、生產(chǎn)和商業(yè)化經(jīng)驗(yàn)的管理團(tuán)隊(duì)的帶領(lǐng)下，諾誠健華已構(gòu)建起一體化的生物醫(yī)藥平臺(tái)，包括藥物晶型研究平臺(tái)、難溶性藥物增溶制劑技術(shù)研發(fā)及產(chǎn)業(yè)化平臺(tái)、生物大分子發(fā)現(xiàn)和工程化改造平臺(tái)等，加速為全球腫瘤和自身免疫性疾病患者開發(fā)并提供極具市場前景的創(chuàng)新療法。發(fā)展至今，諾誠健華現(xiàn)有員工1200多人，眾多員工擁有海外工作和世界500*強(qiáng)藥企工作經(jīng)驗(yàn)，并擁有多名國家*級(jí)、省市級(jí)人才專家。諾誠健華在北京、南京、上海、廣州、香港和美國等多地均設(shè)有分支機(jī)構(gòu)。
公司主頁